Simon Pernot

机构：Institut Bergonié, Azienda Ospedaliera Universitaria Pisana · ORCID：0000-0003-4580-585X

发表论文 209 篇 · 总被引 6227 次 · h-index 31

代表论文

• TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 26)
• Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors (2025 · Journal for ImmunoTherapy of Cancer · 被引 15)
• Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors (2025 · European Journal of Cancer · 被引 13)
• Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis (2025 · Nature Cancer · 被引 9)
• Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer (2025 · EMBO Molecular Medicine · 被引 8)
• Inhibition of PCSK9 Attenuates Liver Endothelial Cell Activation Induced by Colorectal Cancer Stem Cells During Liver Metastasis (2025 · Cancers · 被引 7)